Founded in Baldwin Park, United States, StemCyte Inc. is dedicated to providing umbilical cord blood stem cell products for the treatment of life-threatening diseases. The company's core mission is to harness the potential of stem cells to save or improve lives. StemCyte offers cord blood products to transplant centers worldwide, focusing on leveraging the regenerative capabilities of stem cells to treat various medical conditions.
Notable affiliated individuals and investors include key figures in the medical and scientific communities who support StemCyte's mission. The company has achieved significant milestones, such as contributing to 1 out of every 26 cord blood transplants globally, part of the over 60,000 transplants performed worldwide. StemCyte's impact is profound, positioning it as a global leader in developing new treatments using newborn stem cells.
